We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
576.00 | 5.07% | 11,928.00 | 11,928.00 | 11,930.00 | 12,086.00 | 11,850.00 | 11,890.00 | 571,651 | 08:54:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.18 | 185.68B |
Date | Subject | Author | Discuss |
---|---|---|---|
16/10/2019 14:21 | seems that AZN is just a currency play as falls fast when cable moves higher. But after US futures market opens at about 11.30am , the price here slavishly follows US price . daily swings are not big enough % wise to be able to make much trading it and need a faster trigger finger than I have ! | arja | |
11/10/2019 09:04 | hammered today I see with stronger sterling on hoped of no deal being avoided . sad when dow futures roaring and I wish I had not kept a few overnight ! | arja | |
04/10/2019 10:25 | that sounds good I guess Cheshire . I tend to trade more nowadays either a day trade or keeping a stock it a few days and AZN certainly is a good stock for doing that and better than GSK I think . recovering now after the correction but much now depends on how US markets perform and whether a mini crash happens there again | arja | |
03/10/2019 22:21 | Thanks arja. Emerging Markets and Japan identified as growing areas for AZN on the Hargreaves Lansdowne site. | cheshire pete | |
01/10/2019 08:30 | cheshire pets, sorry for delay in answering as I was abroad for a few days . It just means " no overhead resistance" when a share price breaks through to a higher level not seen previously . I notice AZN down in last day or so with disappointing announcement and share prices of drug companies can be volatile I guess as a lot of news flows . i am not sure if USA or UK is LEAD market for this stock . | arja | |
27/9/2019 22:27 | arja, not a chartist, could you explain NOR please. Tried googling it. Long on AZN in ISA. | cheshire pete | |
25/9/2019 14:47 | a pity AZN is not for trading even though it is very volatile most days . Problem is that no point in making peanuts on a 50p move witb a CFD as poor % gain after commission. | arja | |
24/9/2019 16:08 | yes, chart looks good and I think it is a NOR situation over $75 level . | arja | |
24/9/2019 14:25 | My "chartist" mate says stay long, could test £75 again. | jackdaw4243 | |
17/9/2019 10:20 | has come to life today on bad day in market . Not sure why ! | arja | |
16/9/2019 09:36 | looking ominous for AZN and even down when pound weaker . I wonder if the party is finally over but hoping not ! | arja | |
10/9/2019 15:19 | I notice that AZN here trades at about a 50p discount t AZN in USA ! | arja | |
10/9/2019 14:05 | sounds ominous but have seen this type of report before and not much came of it . These big companies have plenty of clout | arja | |
10/9/2019 13:46 | Healthcare stocks were the worst performers on the FTSE 100 on Monday, as pharmaceutical giants AstraZeneca and GlaxoSmithKline both suffered following reports that American lawmakers plan a legislative crackdown on runaway prescription drug prices in the US. In a rare display of co-operation, Donald Trump’s White House and politicians in the Democrat-controlled House of Congress are both tackling the issue, in which companies ramp up prices of essential medicine. The Washington Post reported that Nancy Pelosi, house speaker, is preparing to unveil drug pricing legislation “as early as this week” – setting the stage for an intense period of drafting before the political agenda is overwhelmed by the run-up to next year’s presidential election. There are a number of measures that could be introduced, but at their heart most would have the same outcome: reducing the cost of drugs. That would hurt the margins of pharmaceuticals companies, including Astra and GSK. | triktrak | |
10/9/2019 13:23 | yes, I notice there is and then 6400 is worst case scenario. might depend a little on how US markets perform and is US market the lead market for this dual listed stock ??. It certainly is for RIO which reacts to RIO in USA after 2.30pm | arja | |
10/9/2019 13:21 | really ? I will check it more closely . | arja | |
10/9/2019 13:15 | Arja, gap to fill at 65 though | p0pper | |
10/9/2019 13:14 | yes, really on the skids with chart support at about 6600. every mini rally today getting hit by sellers and goes to a new low for day . But this stock can turn around suddenly and go on a run. | arja | |
10/9/2019 12:57 | it seems investors are dumping healthcare stocks indiscriminately (Glaxo Smith & Nephew Merck all down) | smcni1968 | |
10/9/2019 11:15 | Hmm, always take profits when u can! | chc15 | |
10/9/2019 07:25 | AstraZeneca Plc : Deutsche Bank raises price target to 7800p from 7600p | nick100 | |
09/9/2019 10:51 | wow , hit today on pound strength and presumably the news announcement not well received . Might be oversold in day and a day trade is tempting | arja | |
05/9/2019 21:58 | Glaxo down a similar percentage. It's all a bit silly. | smcni1968 | |
05/9/2019 13:28 | well, it has moved up a cent and a bit but surely that does not account for the sharp fall today . However , chart still shows a lovely short term and longer term uptrend . | arja |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions